Fundación MD Anderson Cancer Center España

What Fundación MD Anderson Cancer Center España does

Fundación MD Anderson Cancer Center España is a private non-profit foundation registered in the Spanish Registry of Foundations (No. 573), dedicated to cancer eradication through translational research, professional training, and public awareness. It operates from C/ Arturo Soria, 270 in Madrid, sharing its address with the affiliated MD Anderson Cancer Center Madrid - Hospiten facility, which provides direct clinical infrastructure. The foundation runs a multi-program portfolio spanning a Phase I Clinical Trials Unit, translational research lines across breast, gynecological, hematological, digestive, and genomic cancers, a biobank for biological sample storage, and the DIPCAN study — an integrated data platform aggregating clinical, genomic, anatomopathological, and radiological data from 2,000 metastatic cancer patients. It also operates a 320 sq m, 134–160 seat auditorium used for medical events and conferences, and provides specialist education through the 'Investiga por la vida' platform.

The foundation's technology stack centers on precision oncology research, including digital pathology through the Hamamatsu NanoZoomer S540D scanner under Project DAISY, and AI-assisted oncological diagnosis via a strategic alliance with Histofy and Smart In Media. Other research initiatives include the 'El Sabor Perdido' culinary program (with Universidad Francisco de Vitoria, Le Cordon Bleu Madrid, and Chef Ramón Freixa) for taste-loss rehabilitation and the 'Moonshot' program for innovative therapeutic approaches. The foundation is a member of the Asociación Española de Fundaciones and maintains research collaborations with Universidad Autónoma de Madrid and CSIC.

The business model is non-commercial: the foundation is funded entirely through tax-exempt donations from individuals, corporations, and organizations, supplemented by event-based fundraising (golf tournaments, solidarity runs, Giving Tuesday) and project-specific giving for named research programs. Services — including patient-facing support, education, and access to clinical trials — are provided free of charge. Its go-to-market is event-driven and community-led: sports tournaments, TV visibility (e.g., MasterChef Junior via the 'Sin Miedo a Vivir' campaign), the educational 'Investiga por la vida' platform, social media (Facebook, Instagram), and an active volunteer program that recently marked 10 years of operation. Customer segments span cancer patients and survivors, healthcare professionals seeking specialist training, and the general public for awareness and donation engagement.

Name

Fundación MD Anderson Cancer Center España

Legal name

Fundación MD Anderson Cancer Center España

Website

https://fundacionmdanderson.es

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Fundación MD Anderson Cancer Center España is a Spanish non-profit foundation that drives cancer research, prevention, and professional education, operating clinical trials, a biobank, and the DIPCAN multi-modal data study for metastatic cancer patients, funded through tax-exempt donations and event-based fundraising.

Ownership category

akta.pro rank

Product category

Oncology Research and Patient Support Services

NAICS

Voluntary Health Organizations (813212), Grantmaking Foundations (813211), Grantmaking and Giving Services (81321)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industries

Health & Medical Research Grantmaking Foundations (BPAGAKAL), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Cancer research foundation
• Oncology clinical trials
• Translational research
• Cancer biobank services
• Oncology medical education

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Donations and Charitable Contributions: The foundation receives donations from individuals, corporations, and organizations. Donations are tax-exempt for donors as stated on their website (inscribed in Registry of Foundations No. 573).
2. Event Fundraising: Revenue generated from sports events (golf tournaments, running events), charitable activities, and awareness campaigns like Giving Tuesday.
3. Project-Specific Donations: Designated donations for specific research projects such as breast cancer, genomics, obesity and breast cancer, psycho-oncology, and hematological neoplasms.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

The foundation is a non-profit organization that funds and conducts cancer research (translational, clinical trials including Phase I, and multi-omics studies such as DIPCAN on 2,000 metastatic cancer patients), provides specialist oncology training and continuing education, and runs cancer awareness, prevention, and patient-support programs (volunteering, psycho-oncology, 'Sin Miedo a Vivir' campaign). It also maintains a biobank of biological samples and operates an auditorium for medical events.

Product overview

Fundación MD Anderson Cancer Center España - Hospiten is a non-profit foundation dedicated to eradicating cancer through research, prevention, and education. The organization operates as a unified portfolio of interconnected programs: it conducts translational research across multiple cancer types (breast, gynecological, hematological, digestive, and genomic research) through its clinical trials unit and dedicated studies like DIPCAN; maintains a biobank for biological sample storage; provides specialist education and training for healthcare professionals; and offers volunteer programs for patient support. The foundation also operates an auditorium facility for events and lectures. Key research initiatives include Project DAISY (digital transformation of oncological diagnosis with Hamamatsu NanoZoomer S540D), the El Sabor Perdido culinary program for taste rehabilitation, and strategic AI partnerships for pathological diagnosis.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 2,000 metastatic cancer patients enrolled in comprehensive data study (DIPCAN)
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Histofy and Smart In MediacoreTechnology or IntegrationStrategic alliance announced for the application of artificial intelligence to oncological diagnosis. Part of the foundation's digital transformation initiative in cancer diagnosis in Spain.
• Universidad Autónoma de Madrid (UAM)coreStrategic or Co-development PartnerRenewed commitment to drive research in individualized therapies for cancer treatment and diagnosis. Long-standing partnership supporting precision oncology research.
• Universidad Francisco de Vitoria and Le Cordon Bleu MadridminorStrategic or Co-development PartnerCollaboration agreement enabling cancer patients to enjoy food again. Chef Ramón Freixa partnership under 'El sabor perdido' (The Lost Flavor) project to address taste loss in oncology patients.
• Fundación Siglo FuturominorStrategic or Co-development PartnerRenewed collaboration continuing the 'Medicina y Salud Pública' (Medicine and Public Health) Conference Series.
• Chef Ramón FreixaminorStrategic or Co-development PartnerPartnership with chef Ramón Freixa to help oncology patients regain enjoyment of food through the 'El sabor perdido' (The Lost Flavor) project.
• MD Anderson Cancer Center Madrid - HospitencoreStrategic or Co-development PartnerAffiliated cancer center providing clinical services, sharing the MD Anderson brand and network. Located at same address as foundation headquarters.
• Hospiten GroupcoreStrategic or Co-development PartnerHealthcare network affiliated with the foundation, providing institutional support and operational infrastructure.
• Asociación Española de FundacionesminorStrategic or Co-development PartnerSpanish Association of Foundations membership, providing institutional credibility and networking within the Spanish non-profit sector.
• Sin Miedo a Vivir MovementminorStrategic or Co-development PartnerMovement positioning cancer patients as inspiration for society. Foundation participates in awareness and visibility campaigns.
• CSIC (Consejo Superior de Investigaciones Científicas)minorStrategic or Co-development PartnerResearch collaboration on antitumor effects of Gasdermina B in breast cancer, published study results.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Fundación "la Caixa": Large Spanish philanthropic foundation with a significant health-research grants program (including oncology). Broader mandate but overlapping donor base and competitive for high-value health-research gifts in Spain.
• Cancer Research UK: UK-based charity funding cancer research, clinical trials, and patient information at substantial scale. Comparable disease focus, donor-supported research model, and translational-to-clinical pipeline orientation.
• American Cancer Society: The world's largest voluntary health organization focused on cancer, funding research, patient services, and education. Comparable mission, donation-driven model, and translational research portfolio at global scale.
• Centro Nacional de Investigaciones Oncológicas (CNIO): Spain's premier public cancer research center running translational and basic research programs. Comparable oncology research focus and frequent co-funding partner for Spanish cancer research projects.

Direct peers

• Fundación CRIS Contra el Cáncer: Spanish non-profit foundation exclusively funding translational and clinical cancer research, including investigator-initiated trials and early-phase studies. Highly comparable scope, funding model, and Spanish research-hospital partnerships.
• Asociación Española Contra el Cáncer (AECC): Spain's largest cancer-focused non-profit, funding cancer research, patient support, and awareness. Most direct domestic counterpart to Fundación MD Anderson España given overlapping disease focus, donation-driven model, and translational research grants.
• Fundación Científica de la Asociación Española Contra el Cáncer: The research-grantmaking arm of AECC, awarding competitive grants to Spanish oncology research groups. Comparable grant-program design, peer-review process, and Spanish investigator base as the foundation's translational research portfolio.

Emerging players

• Worldwide Cancer Research: Smaller UK-based charity funding early-stage, high-risk cancer research globally. Comparable in funding early/translational research and leveraging donor contributions, though more limited geographic reach.

Others

• Hospiten Group: Private Spanish healthcare-hospital network that provides institutional infrastructure and partnership to the foundation. Not a peer competitor but a material operational/strategic stakeholder given shared locations and overlapping patient flow.

Regional players

• Institut Català d'Oncologia (ICO): Public Catalan cancer care and research network conducting translational oncology research and clinical trials. Comparable translational research and trial portfolio, but limited to Catalonia rather than operating nationally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/fundacionmdandersonhospitenES
• Instagraminstagram.com/fundacionmdandersonhospiten_es
• LinkedInlinkedin.com/company/fundaci%C3%B3n-md-anderson-cancer-center-espana

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fundación MD Anderson Cancer Center España